Publication | Closed Access

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

Percutaneous Coronary InterventionProspective Open-label TrialCardiovascular DiseaseCoronary UnitSurgeryBiomedical EngineeringMedicineCardiologyCoronary Artery Disease